<i>Clostridium difficile</i> Infection – Symptoms, Treatment, and Dietary Recommendations

*Clostridium difficile* is a gram-positive, obligately anaerobic bacillus capable of asymptomatically colonizing the gastrointestinal tract in a subset of the population. In individuals with an undisturbed gut microbiome, it persists as a commensal organism; however, disruption of microbial equilibrium—particularly due to antibiotic exposure, especially prolonged or combination regimens (involving two or more agents)—can precipitate acute colitis, frequently accompanied by mucosal damage and pseudomembranous plaque formation. The infection disproportionately affects elderly individuals, particularly those in long-term care facilities or hospitals, where transmission occurs primarily via fomites or contaminated medical equipment. Additional predisposing factors include reduced mobility (partial or complete immobilization), chemotherapy-induced or iatrogenic immunosuppression, and chronic conditions compromising immune function. Recent epidemiological trends indicate a concerning rise in cases among younger adults and middle-aged individuals without prior hospitalization or antibiotic use—a phenomenon termed *community-acquired* *C. difficile* infection (CA-CDI). Estimates suggest that up to 20% of hospitalized patients (predominantly those receiving antibiotics) may harbor *C. difficile*, though only approximately 30% progress to symptomatic colitis. Preventive measures hinge on stringent hygiene protocols, including alcohol-based hand sanitization and isolation of infected individuals.

*Clostridioides difficile* infection (formerly referred to as *Clostridium difficile*) primarily presents with persistent, watery diarrhea that is typically devoid of blood. Initial symptoms most commonly emerge between the fifth and tenth day of antibiotic administration. In severe cases—particularly when pseudomembranous colitis develops—patients may additionally experience high fever, pronounced abdominal distension, and acute abdominal pain. These manifestations arise due to the action of enterotoxins (toxin A) and cytotoxins (toxin B) secreted by the bacteria, which induce damage, sloughing, and necrotic destruction of the intestinal epithelial lining. Notably, in approximately 10–15% of the most severe cases, a paradoxical reduction in bowel movement frequency may occur alongside worsening distension and pain—a condition that may indicate the development of colonic obstruction and pose an immediate threat to life. Symptoms may manifest either during antibiotic treatment or up to three weeks following its discontinuation. Any concerning symptoms, particularly antibiotic-associated diarrhea, should prompt immediate medical evaluation to distinguish the condition from other causes, such as simple antibiotic-induced diarrhea, thereby preventing delays in accurate diagnosis.

The diagnosis of *Clostridioides difficile* infection (formerly *Clostridium difficile*) relies on the detection of bacterial toxins in stool samples using immunological assays or nucleic acid amplification tests (NAAT). In clinically ambiguous cases, lower gastrointestinal endoscopy with tissue biopsy for histopathological evaluation may be warranted. For mild infections, discontinuation of ongoing antibiotic therapy often suffices to achieve spontaneous symptom resolution. However, moderate to severe cases necessitate targeted antimicrobial intervention—typically metronidazole (for mild-to-moderate presentations) or oral vancomycin (for severe cases requiring hospitalization). Fidaxomicin may also be considered in certain treatment regimens. Adjunctive therapies, such as probiotic supplementation (particularly with *Saccharomyces boulardii*) and short-term systemic corticosteroid administration, may be explored as supportive measures. The standard treatment duration ranges from 10 to 14 days, though approximately 25% of patients experience recurrent infections—a phenomenon attributed to the bacterium’s capacity to form resilient endospores, enabling survival under adverse conditions. Emerging evidence suggests that probiotics containing *S. boulardii* may significantly reduce recurrence risk. Among the most severe complications—demanding immediate medical attention—are pseudomembranous colitis (characterized by a fulminant course and resistance to conventional therapies), toxic megacolon, colonic perforation, and systemic sepsis, all of which pose a direct threat to life.

While Clostridium difficile infection primarily arises from disruption of gut microbiota due to prolonged antibiotic use, a meticulously balanced diet plays a pivotal role in mitigating clinical symptoms such as persistent diarrhea. Proper nutrition prevents metabolic complications, including dehydration, electrolyte imbalances, and protein deficiencies. A low-residue diet with restricted intake of fats, dietary fiber, lactose, and simple sugars is essential. Frequent, small meals with mild flavors and soft textures support gastrointestinal recovery, whereas specific foods may further reduce diarrhea frequency.